There are 503 papers on cervical cancer in aging research: 15 trials and 270 observational studies in people, 2 in animals, 11 in cells, 140 reviews.
503 papers study it216 more mention it93 findings
81 new papers in 30 daysSee all 719 papers on cervical cancer
At a glance
Cervical cancer is linked with older age and poorer recall in human studies, and with lower cellular senescence than cervical intraepithelial neoplasia in human tissue. Human cohorts associate HPV vaccination with lower cervical cancer risk, while a screening implementation study reports less advanced-stage disease; reviews also describe prevention through vaccination and screening.
93 findings in 76 papers from 2016 to 2026, 34 of them since April 2026
“cervical cancer (HR, 1.31; 95% CI, 1.13-1.51, p < 0.001)”
- Human trial15
- Humans270
- Animals2
- Cells11
- In silico62
Interventions
10Cervical cancer screening
downin humans3−43%
3 studies
Cervical cancer screening
downin humans3−43%
Cervical cancer screening is linked with lower cervical cancer in humans (advanced-stage (III-IV) disease after KOFIH and UNFPA/UNDP implementation) (-43%).
“while the proportion of advanced-stage (III-IV) disease declined by 43%”
Humansadvanced-stage (III-IV) disease after KOFIH and UNFPA/UNDP implementationcervixfemalesn = 2,140
Population‑based registry analysis of cervical cancer trends in Tashkent Uzbekistan 2014-2024
JNCI cancer spectrum
Cervical cancer screening decreases cervical cancer in humans (national roll-out of Programme ZORA).
“Cervical and colorectal cancer incidence and mortality are decreasing”
Reviewnational roll-out of Programme ZORA
Zdravstveno varstvo
Cervical cancer screening prevents cervical cancer in humans.
“Current guidelines do not adequately address these changes, and may be missing significant opportunities to prevent cervical cancer cases and deaths in older women.”
Reviewfemales
It's time to re-evaluate cervical Cancer screening after age 65
Gynecologic oncology
Smoking
no changein humans1
1 study
Smoking
no changein humans1
Smoking was not clearly linked with cervical cancer in humans (East Asian populations).
“MR analysis did not identify statistically significant causal associations between any smoking-related exposure factors and CC risk”
HumansEast Asian populations
Medicine
Vaccination
downin humans1
1 study
Vaccination
downin humans1
Vaccination prevents cervical cancer in humans (for HPV- and HBV-related cancers).
“HPV- and HBV-related cancers are largely preventable through vaccination, although coverage remains uneven across Asia.”
Reviewfor HPV- and HBV-related cancers
Infection-driven cancers in Asia: implications from epidemiological transitions
The Lancet regional health. Western Pacific
HPV vaccination
downin humans1
1 study
HPV vaccination
downin humans1
HPV vaccination prevents cervical cancer in humans.
“Cervical cancer remains a leading cause of cancer-related mortality among women, despite being largely preventable through Human Papillomavirus (HPV) vaccination, HPV screening, and treatment.”
Reviewcervixfemales
Challenges and possible solutions towards reaching global cervical cancer elimination
EClinicalMedicine
LY3177833 + paclitaxel
downin mice1
1 study
LY3177833 + paclitaxel
downin mice1
LY3177833 + paclitaxel decreases cervical cancer in vivo xenograft models.
“in vivo models validating suppressed tumor growth”
Animalsin vivo xenograft models
A senescence-based machine learning model prognosticates and personalizes therapy in cervical cancer
Translational cancer research
HPV vaccine
downin humans1
1 study
HPV vaccine
downin humans1
HPV vaccine prevents cervical cancer in humans (no new cases).
“no new cases of cervical cancer have been detected in a cohort of Scottish women vaccinated against HPV between 12-13 years old”
Reviewcervixfemales
British journal of hospital medicine (London, England : 2005)
Self-collection cervical screening
no changein humans1OR 0.71
1 study
Self-collection cervical screening
no changein humans1OR 0.71
Self-collection cervical screening was not clearly linked with cervical cancer in humans (women referred for colposcopy with HPV 16/18) (adjusted OR 0.71, 95% CI 0.36-1.40).
“Histological detection of cancer was similar between self-collected and clinician-collected samples, both for those with HPV 16/18 (adjusted OR 0·71 [95% CI 0·36-1·40])”
Humanswomen referred for colposcopy with HPV 16/18self-collected vs clinician-collected samplesfemales
The Lancet. Public health
Screening
downin humans1
1 study
Screening
downin humans1
Screening prevents cervical cancer in humans.
“the disease can be prevented by screening”
Review
Human Papillomavirus Screening: Design and Targeting of Human Papillomavirus Genotypes
Current topics in microbiology and immunology
Early menopause
no changein humans1
1 study
Early menopause
no changein humans1
Early menopause was not clearly linked with cervical cancer in humans (aOR 1.435, 95% CI 0.730-2.821).
“There was no association between early menopause and cervical cancer (adjusted odds ratio [aOR]: 1.435, 95% confidence interval [CI]: 0.730-2.821)”
Humansfemalesn = 4,481
Asian Pacific journal of cancer prevention : APJCP
Repeat cytology
no changein humans1
1 study
Repeat cytology
no changein humans1
Repeat cytology was not clearly linked with cervical cancer in humans (Incidence rate ratio 1.1, 95% CI 0.5–2.5).
“had a similar risk of cervical cancer compared with colposcopy/biopsy”
HumansAfter atypical squamous cells of undetermined significance; compared with colposcopy/biopsycervixWithin 6 monthsfemales
American journal of obstetrics and gynecology
Effects
3SAT1
upin human cells1
1 study
SAT1
upin human cells1
Cervical cancer increases SAT1 in human cells.
“We identified elevated expression of the rate-limiting SPD metabolic enzyme SAT1 in cervical cancer tissues.”
Cellscervical cancer tissues
SAT1-Mediated Spermidine Metabolism Drives Ferroptosis in Cervical Cancer
Research SquarePreprint
Mortality
upin humans1
1 study
Mortality
upin humans1
Cervical cancer is linked with higher mortality in humans (China, 2000-2020) (AAPC = 3.9%).
“while the ASMR rose steadily (AAPC = 3.9%).”
HumansChina, 2000-20202000-2020females
Cancer biology & medicine
SERPINE1
upin human cells1
1 study
SERPINE1
upin human cells1
Cervical cancer increases SERPINE1 in cervical cancer cells and tissues.
“In vitro studies showed increased SERPINE1 and IL-1α ((genes included in the signature) expression in CC cells and tissues”
Cellsin cervical cancer cells and tissues
Research squarePreprint
Upstream
5Time
downin humans1
1 study
Time
downin humans1
time is linked with lower cervical cancer in humans (cervical cancer burden across 34 Asian countries from 1990 to 2023).
“From 1990 to 2023, ASIR and ASDR generally declined across Asia, although substantial regional disparities persisted.”
Humanscervical cancer burden across 34 Asian countries from 1990 to 2023females
European journal of obstetrics, gynecology, and reproductive biology
Later menopause
no changein humans1
1 study
Later menopause
no changein humans1
Later menopause was not clearly linked with cervical cancer in humans.
“but not cervical cancer, confirming distinct human papillomavirus (HPV)-driven etiology”
Humansfemalesn = 143,819
iScience
Senescence-associated secretory phenotype (SASP)
mediatesin humans1
1 study
Senescence-associated secretory phenotype (SASP)
mediatesin humans1
Senescence-associated secretory phenotype (SASP) mediates cervical cancer in humans (cervical epithelial neoplasia cells).
“biological basis of CIN progression via SASP senescence and ultimately EMT”
Reviewcervical epithelial neoplasia cells
Antioxidants (Basel, Switzerland)
Older-adults
upin humans1
1 study
Older-adults
upin humans1
Older-adults are linked with higher cervical cancer in humans (rural and urban China).
“In contrast, women ≥65 y of age had a steadily increasing incidence and mortality in rural and urban areas.”
Humansrural and urban China2000-2020females
Cancer biology & medicine
HIV infection
no changein humans1
1 study
HIV infection
no changein humans1
HIV infection was not clearly linked with cervical cancer in humans (1.4% in both groups).
“In both groups, 1.4% developed cervical cancer.”
Humansfemalesn = 140
Pap smear outcomes in elderly women living with HIV and HIV-negative matched controls
International journal of STD & AIDS
Associations
53HPV vaccine
downin humans5downin silico2
7 studies
HPV vaccine
downin humans5downin silico2
HPV vaccine is linked with a lower risk of cervical cancer in humans (-1.45 cases per 100,000 population).
“Cervical cancer incidence declined by 1.45 cases per 100,000 population (CI= -1.76, -1.15)”
Humansfemales
Heterogeneous Population-level Cervical Cancer Reductions Following Introduction of HPV Vaccine
Research SquarePreprint
HPV vaccine is linked with a lower risk of cervical cancer in humans (screened women (vaccine-eligible)).
“The reduction in invasive cervical cancer incidence was significantly greater than those observed for CIN2 + and CIN3 +.”
Humansscreened women (vaccine-eligible)females
Journal of infection and public health
HPV vaccine lowers the risk of cervical cancer in silico (1.82 million cases averted (53% reduction)).
“Continuation of Nigeria's current adolescent program is projected to avert 1.82 million cervical cancer cases (IQR 1.65-1.90 million; 95% UI 1.39-2.02 million) over 2025-2100 (a 53% reduction relative to no vaccination”
In silico2025-2100
Model-based evaluation of an infant HPV prophylactic vaccination program in Nigeria
medRxivPreprint
HPV vaccine lowers the risk of cervical cancer in humans.
“Population-based evidence demonstrated reduced cervical cancer incidence among women vaccinated before adolescence.”
Reviewfemales
Cancer investigation
HPV vaccine lowers the risk of cervical cancer in vaccinated populations.
“reductions of cervical precancer and cancer incidence in vaccinated populations”
Reviewin vaccinated populations
How to evaluate and select cervical screening and triage tests in vaccinated populations
Journal of the National Cancer Institute. Monographs
HPV vaccine lowers the risk of cervical cancer in silico (postpartum period) (27 fewer cases).
“and 27 fewer cases of early-stage cervical cancer in our simulated population”
In silicopostpartum periodcervixfemalesn = 400,000
Cost-Effectiveness of an HPV Vaccination Program in the Postpartum Period
Journal of women's health (2002)
HPV vaccine lowers the risk of cervical cancer in humans.
“HPV vaccination reduces the risk of cervical and other cancers”
Review
Cancer Prevention Must Begin Earlier: A Life-Course Perspective
Developmental medico-life-sciences
Human papillomavirus infection
upin humans4
4 studies
Human papillomavirus infection
upin humans4
Human papillomavirus infection is linked with a higher risk of cervical cancer in humans (AAPC 5.89% (95% CI: 2.82-9.06)).
“From 1988 to 2017, the ASRs increased for HPV-attributable cervical cancer (females; average annual percent change [AAPC] and 95% CI: 5.89% [2.82-9.06])”
Humansfemales
BMC public health
Human papillomavirus infection is associated with cervical cancer in humans (HPV detection in tumor tissue versus CIN) (61% of tumor tissues vs 25% of CINs HPV-positive).
“Infection of HPV was confirmed in 61% of the tumor tissues while only 25% of the CINs were positive for HPV.”
HumansHPV detection in tumor tissue versus CINcervixn = 37
Resolution of oncogene-induced senescence markers in HPV-infected cervical cancer tissue
BMC cancer
Human papillomavirus infection raises the risk of cervical cancer in humans (Causes nearly all cervical cancers).
“Persistent high-risk HPV infection causes nearly all cervical cancers, predominantly HPV16/18, with regional variation in other types.”
Reviewpersistent high-risk infectionfemales
Journal of clinical medicine
human papillomavirus infection is associated with cervical cancer in humans.
“Human papillomavirus (HPV) infection is the most common sexually transmitted disease associated with the development of cervical intraepithelial neoplasia and cervical cancer”
Review
HPV infection and its significance in the development and prevention of cervical cancer
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Unsafe sex
upin humans3
3 studies
Unsafe sex
upin humans3
Unsafe sex is associated with cervical cancer in humans (low-SDI regions; risk attribution analysis) (>90% of cervical cancer risk).
“unsafe sex (accounting for >90% of cervical cancer risk)”
Humanslow-SDI regions; risk attribution analysis
Frontiers in oncology
unsafe sex is linked with a higher risk of cervical cancer in humans (cervical cancer burden in Asia).
“Cervical cancer burden attributable to unsafe sex showed the highest DALY rate among females aged 50-69 years and the highest mortality rate among those aged 70 years or older.”
Humanscervical cancer burden in Asiafemales
European journal of obstetrics, gynecology, and reproductive biology
Unsafe sex is linked with a higher risk of cervical cancer in humans (leading risk factor).
“Unsafe sexual practices are the leading risk factor for cervical cancer, dietary risks for breast cancer, and high body mass index for uterine and ovarian cancers.”
Humansleading risk factorfemales
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Cervical cancer screening
downin humans1upin humans1downin silico1
3 studies
Cervical cancer screening
downin humans1upin humans1downin silico1
Cervical cancer screening is associated with cervical cancer in humans (ρ = 0.85, p < 0.001).
“Correlation analysis revealed strong positive associations between higher screening coverage and the deceleration of incidence (ρ = 0.85, p < 0.001)”
Humansfemales
Cervical Cancer Incidence and Mortality Trends in China: The Role of Screening
Cancer letters
Cervical cancer screening is associated with cervical cancer in humans (83 cases vs around 64).
“In 2009-2016, number of incident cervical cancers in women aged 70+ in Denmark fluctuated around 64; in 2017 it reached 83 cases”
Humansfemales
A cervical screening initiative for elderly women in Denmark
Acta obstetricia et gynecologica Scandinavica
Cervical cancer screening lowers the risk of cervical cancer in silico (WHO targets scale-up (70% aggregate)) (~387K cases averted).
“Scaling up screening to WHO targets was estimated to avert a further ~387K cases (IQR 331-424K; 95% UI 269-515K), roughly 25% of the residual burden”
In silicoWHO targets scale-up (70% aggregate)2025-2100
Model-based evaluation of an infant HPV prophylactic vaccination program in Nigeria
medRxivPreprint
Age
upin humans3
3 studies
Age
upin humans3
Age is linked with a higher risk of cervical cancer in humans (aOR 1.043, 95% CI 1.004–1.083).
“increasing age (adjusted OR [aOR] = 1.043, 95% CI: 1.004–1.083; P = 0.030)”
Humansfemales
Research SquarePreprint
Age is associated with cervical cancer in humans (38.2% abnormality rate, 5.1% carcinoma detection).
“The 51-60 years age group demonstrated the highest abnormality rate (38.2%) and carcinoma detection (5.1%).”
Humanscervixfemalesn = 5,067
International Journal of Clinical and Diagnostic Pathology
Age is associated with cervical cancer in humans (95 cases per 100,000).
“Cervical cancer incidence peaked in women aged 55-59 (95 cases per 100,000)”
Humansfemales
Scientific reports
HIV infection
downin humans1upin humans1
2 studies
HIV infection
downin humans1upin humans1
HIV infection is associated with cervical cancer in humans (hysterectomy-corrected, 2015-2019 vs 2001-2004) (IRR=0.78, 95%CI: 0.63,0.97).
“Compared with 2001-2004, corrected ASIRs were lower in 2005-2009 (IRR=0.79, 95%CI: 0.65,0.96); 2010-2014 (IRR=0.75, 95%CI: 0.61,0.91); and 2015-2019 (IRR=0.78, 95%CI: 0.63,0.97).”
Humanshysterectomy-corrected, 2015-2019 vs 2001-2004cervixfemalesn = 933
Journal of the National Cancer Institute
HIV infection raises the risk of cervical cancer in humans (approximately three times).
“WLHIV face approximately three times the cervical cancer incidence of HIV-negative women”
Reviewfemales
International journal of women's health
Older age
upin humans2RR 4.11
2 studies
Older age
upin humans2RR 4.11
Older age is linked with a higher risk of cervical cancer in humans (compared with participants aged <45 years) (aRR 5.02, 95% CI 2.43-10.35).
“5.02 (2.43-10.35) for cervical cancer”
Humanscompared with participants aged <45 years
Frontiers in public health
Older age is linked with a higher risk of cervical cancer in humans (squamous cell abnormalities in Pap smear) (RR 4.11, 95% CI: 3.72-4.54).
“For cervical cancer (RR 4.11, 95% CI: 3.72-4.54), the diagnosis rate was significantly higher in women over 70.”
Humanssquamous cell abnormalities in Pap smearfemalesn = 450,349
Research SquarePreprint
Human papillomavirus vaccine
downin humans2
2 studies
Human papillomavirus vaccine
downin humans2
Human papillomavirus vaccine lowers the risk of cervical cancer in humans.
“vaccines have the anticipated effect against infection, lesions, and ultimately invasive cervical cancer”
Review
Journal of the National Cancer Institute. Monographs
Human papillomavirus vaccine lowers the risk of cervical cancer in humans.
“has been shown to reduce the incidence and mortality of cervical cancer”
Review
HPV infection and its significance in the development and prevention of cervical cancer
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
HPV self-sampling
downin humans2
2 studies
HPV self-sampling
downin humans2
HPV self-sampling is linked with a lower risk of cervical cancer in humans (-27% (7.7/100,000 in 2024 vs 11-12 per 100,000 in 2015-2020)).
“A rapid introduction of primary HPV self-sampling at home in 2020-2021 was followed by a rapid decline in invasive cervical cancer incidence.”
Humansfemales
Preventive medicine
HPV self-sampling is linked with a lower risk of cervical cancer in humans (nationwide switch to primary screening) (7.7/100,000 in 2024 (-27% in all ages)).
“From 2021 and onwards the incidence is declining and was 7,7/100,000 in 2024.”
Humansnationwide switch to primary screeningfemales
medRxivPreprint
Ulcerative colitis
no changein humans1upin humans1HR 1.56–3.65
1 study
Ulcerative colitis
no changein humans1upin humans1HR 1.56–3.65
Ulcerative colitis is associated with cervical cancer in humans with reference to the control group (HR 1.56 (95% CI 0.97-2.50)).
“The adjusted HR for cervical cancer was 1.56 (95% CI 0.97-2.50) in the UC group with reference to the control group.”
Humanswith reference to the control groupfemales
Elevated risk of cervical cancer in elderly women with incident ulcerative colitis in South Korea
Scientific reports
Ulcerative colitis is linked with a higher risk of cervical cancer in humans (elderly UC patients (≥ 60 years) compared to elderly control group) (HR 3.65 (95% CI 1.54-8.66)).
“adjusted HR for cervical cancer was 3.65 (95% CI 1.54-8.66) in elderly UC patients (≥ 60 years) compared to elderly control group (≥ 60 years)”
Humanselderly UC patients (≥ 60 years) compared to elderly control groupfemales
Elevated risk of cervical cancer in elderly women with incident ulcerative colitis in South Korea
Scientific reports
All 53Fewer
Trial sponsors
Company1 trialPhase 4540 people
Company1 trialPhase 4175 people
Company5 trialsPhase 33,942 people
Company3 trialsPhase 3849 people
Company2 trialsPhase 3365 people
Company1 trialPhase 3445 people
Jiangsu Hengrui Pharmaceuticals
Company1 trialPhase 3443 people
Company1 trialPhase 3440 people
Funding
189 grants since 2016National Cancer Institute$148MNational Institute on Minority Health and Health Disparities$7.3MCancer Prevention and Research Institute of Texas$25.3M
National Cancer InstituteBasic Health International$1.5M2024–2029
Enhancing Cervical Cancer Screening through Integrated Care in Rural North Carolina
National Cancer InstituteUniv of North Carolina Chapel Hill$607K2026–2031
National Cancer InstituteComprehensive Cancer Center/ Univ/pr$17.7K2023–2028
Comparative Modeling to Inform Cervical Cancer Prevention Policies and Practice in the United States
National Cancer InstituteTulane University of Louisiana$1.1M2026–2031
National Cancer InstituteUniversity of Tx Md Anderson Can Ctr$68.8K2023–2028
The Empilisweni Initiative - Advancing Implementation of Cervical Cancer Control
National Cancer InstituteColumbia University Health Sciences$214K2023–2028
mSaada: A Mobile Health Tool to Improve Cervical Cancer Screening in western Kenya
National Cancer InstituteDuke University$42.2K2022–2027
National Cancer InstituteUniversity of Miami School of Medicine$2.3M2025–2030
Fogarty International CenterUniversite Joseph Ki-zerbo$125K2026–2031
National Cancer InstituteTulane University of Louisiana$203K2024–2029
How this record changed
Summary rewritten as its findings changed.
As it read before
In humans, older age and human papillomavirus infection increase cervical cancer risk, while smoking shows no effect in an East Asian cohort. Reviews link HPV vaccination to lower risk in females, supported by computational modeling of vaccination and screening.
Summary written from the findings.